New research led by Jamaican master’s graduate Amarley Wright from the University of the West Indies (UWI) Mona campus unveils promising findings in the quest for improved treatment options for type 2 diabetes.
Wright’s study, titled ‘Combined Supplementation of S-Nitro Glutathione and Glutathione Improves Glycaemic Control in Type 2 Diabetic Rats’, delves into the potential of combining antioxidants to lower blood sugar levels in diabetic subjects.
The urgency of addressing diabetes
Type 2 diabetes, affecting between 90 to 95 per cent of diabetes cases globally, remains a pressing health concern.
Wright emphasizes the gravity of the situation, particularly in Jamaica, where 11.6 per cent of the population grapples with the condition.
With diabetes ranking among the leading causes of death on the island, the significance of Wright’s research cannot be overstated.
Unraveling the disease mechanisms
Diabetes, characterized by elevated blood-sugar levels, demands innovative approaches to treatment.
Wright’s study sheds light on the intricate mechanisms underlying the disease, highlighting the role of oxidative stress and the potential of antioxidants like glutathione in mitigating its effects.
Promising results in animal models
In animal models of type 2 diabetes, Wright’s research demonstrates the efficacy of glutathione supplementation in reducing blood-sugar levels.
Furthermore, the combination of glutathione and nitric oxide presents a synergistic effect, showcasing a pronounced reduction in glucose concentration and alleviating diabetes symptoms such as excessive thirst and hunger.
Paving the way for clinical trials
While clinical trials exploring the efficacy of these compounds in human subjects are underway in other countries, Jamaica currently lacks such initiatives.
Wright advocates for further research collaboration to propel these promising findings toward clinical trials, potentially revolutionizing diabetes treatment on the island.
Aiming for improved quality of life
Central to Wright’s research is the aspiration to enhance the quality of life for diabetic patients.
With diabetes prevalence on the rise globally, the economic burden associated with its treatment underscores the urgency for effective pharmaceutical interventions.
Wright’s work offers a glimmer of hope in this endeavor.
Recognizing excellence in research
Wright’s contributions to the field have not gone unnoticed, as evidenced by his receipt of the ‘Best Student Oral Presentation’ award at the 14th Annual National Health Research Conference.
This recognition reaffirms the significance of his research in pursuing innovative solutions to combat diabetes.
 Mona campus unveils){kind=link}